Prevalence and genetic variants of hepatitis GB-C/HG and TT viruses in Gabon, equatorial Africa.

The distribution of Hepatitis GB-C/HG (GB-C/HG) and TT viruses (TTV) infections was investigated in selected populations from Gabon using Polymerase Chain Reaction (PCR) and Enzyme Linked Immunosorbent Assay (ELISA) for anti-Envelop 2 (anti-E2) GBV-C/HGV antibodies. Among pregnant women, 29 of 229 (12.6%) were Hepatitis GB virus-C and Hepatitis G virus (GBV-C/HGV) RNA positive (+) and 32 of 81 (39.5%) anti-E2 + versus 8 of 39 (20.5%) TTV DNA +. Among sickle cell anemia patients, 9.7% (3/31) were GBV-C/HGV RNA + versus 22.5% (7/31) TTV DNA +. For tuberculosis patients, the figures were 11.5% (4/35) and 0%. A study of hepatocellular carcinoma cases (n = 27) versus controls (n = 66) did not show significant differences for GBV-C/HGV RNA (10.7% versus 12.1%) and TTV DNA (44.4% versus 30.3%). According to phylogenetic analysis, the 15 GBV-C/HGV strains investigated clustered in group 1, the most common in sub-Saharan Africa whereas TTV sequences (n = 4) mostly clustered in genotypes G1 and one close to genotype G3. In the Gabonese populations investigated, GBV-C/HGV and TTV infections were highly endemic. These data are consistent with the low pathogenicity of these agents.

[1]  P. Marcellin,et al.  Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases. , 2000, Journal of hepatology.

[2]  池田 広記.  Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA , 2000 .

[3]  H. Okamoto,et al.  Excretion into bile of a novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A-G hepatitis. , 1999, The Journal of infectious diseases.

[4]  A. Yamada,et al.  Identification of a Novel GC-Rich 113-Nucleotide Region To Complete the Circular, Single-Stranded DNA Genome of TT Virus, the First Human Circovirus , 1999, Journal of Virology.

[5]  P. Simmonds,et al.  Early acquisition of TT virus (TTV) in an area endemic for TTV infection. , 1999, The Journal of infectious diseases.

[6]  S. Polywka,et al.  Age-Dependent Acquisition of Hepatitis G Virus/GB Virus C in a Nonrisk Population: Detection of the Virus by Antibodies , 1999, Journal of Clinical Microbiology.

[7]  T. Pilot‐Matias,et al.  Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Matsuo,et al.  Multiple infection of TT virus (TTV) with different genotypes in Japanese hemophiliacs. , 1999, Biochemical and biophysical research communications.

[9]  S. Skidmore,et al.  Prevalence of GB virus‐C/hepatitis G virus infection in an antenatal population , 1999, Journal of medical virology.

[10]  M. Mizokami,et al.  TT virus infection among blood donors and patients with non-B, non-C liver diseases in Korea. , 1999, Journal of hepatology.

[11]  Kyoichi Inoue,et al.  Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA. , 1999, Journal of hepatology.

[12]  F. Roudot-thoraval,et al.  Prevalence of GB virus type C/hepatitis G virus RNA and of anti‐E2 in individuals at high or low risk for blood‐borne or sexually transmitted viruses: evidence of sexual and parenteral transmission , 1999, Transfusion.

[13]  P. Simmonds,et al.  Prevalence, incidence, and clinical characteristics of hepatitis G virus/GB virus C infection in Scottish blood donors. , 1998, The Journal of infectious diseases.

[14]  ller,et al.  Detection of sequences of TT virus, a novel DNA virus, in German patients. , 1998, The Journal of general virology.

[15]  A. Theamboonlers,et al.  Hepatitis TT virus infection in high-risk groups , 1998, Infection.

[16]  H. Okamoto,et al.  Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non‐A‐G hepatitis , 1998, Journal of medical virology.

[17]  J. Bruix,et al.  Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. , 1998, Journal of hepatology.

[18]  T. Therneau,et al.  TT‐virus infection in north american blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis , 1998, Hepatology.

[19]  J. Bruix,et al.  Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action , 1998 .

[20]  P. Simmonds,et al.  Detection of a novel DNA virus (TT virus) in blood donors and blood products , 1998, The Lancet.

[21]  Mark George Thomas,et al.  Presence of a newly described human DNA virus (TTV) in patients with liver disease , 1998, The Lancet.

[22]  E. Vardas,et al.  GB virus C prevalence in blood donors and high risk groups for parenterally transmitted agents from Gauteng, South Africa† , 1998, Journal of medical virology.

[23]  S. Schmolke,et al.  Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion‐associated non‐A, non‐B hepatitis , 1998, Journal of viral hepatitis.

[24]  G. Pardi,et al.  Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. , 1998, The Journal of infectious diseases.

[25]  T. Gojobori,et al.  African origin of GB virus C/hepatitis G virus 1 , 1998, FEBS letters.

[26]  T. Nishizawa,et al.  Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology , 1998 .

[27]  P. Simmonds,et al.  Detection of a novel DNA virus (TTV) in blood donors and blood products. , 1998, Lancet.

[28]  T. Nishizawa,et al.  A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. , 1997, Biochemical and biophysical research communications.

[29]  U. Gelatti,et al.  A case‐control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. , 1997 .

[30]  U. Gelatti,et al.  A case-control study on GB virus C/hepatitis G virus infection and hepatocellular carcinoma. Brescia HCC Study. , 1997, Hepatology.

[31]  S. Staszewski,et al.  Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non‐risk populations , 1997, Journal of medical virology.

[32]  S. Louw,et al.  High prevalence of GBV‐C hepatitis G virus infection in a rural South African population , 1997, Journal of medical virology.

[33]  K. Fry,et al.  Sequence variation and phylogenetic analysis of the 5‘ terminus of hepatitis G virus , 1997, Journal of viral hepatitis.

[34]  T. Leary,et al.  Identification of GB virus C variants by phylogenetic analysis of 5'-untranslated and coding region sequences , 1997, Journal of virology.

[35]  N. Cuceanu,et al.  Discrimination of hepatitis G virus/GBV-C geographical variants by analysis of the 5' non-coding region. , 1997, The Journal of general virology.

[36]  K. Masuko,et al.  Mutation rate of GB virus C/hepatitis G virus over the entire genome and in subgenomic regions. , 1997, Virology.

[37]  H. Alter.  G‐pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus , 1997, Transfusion.

[38]  S. Viazov,et al.  Genetic heterogeneity of hepatitis G virus isolates from different parts of the world. , 1997, The Journal of general virology.

[39]  M. Hijikata,et al.  Characterization of GBV-C/HGV viral genome : comparison among different isolates for a ∼2 kb-sequence that covers entire E1 and most of 5'UTR and E2 , 1997 .

[40]  J. Rosenblatt,et al.  Prevalence studies of GB Virus‐C infection using reverse transcriptase‐polymerase chain reaction , 1996, Journal of medical virology.

[41]  T. Pilot‐Matias,et al.  Sequence heterogeneity within the 5'-terminal region of the hepatitis GB virus C genome and evidence for genotypes. , 1996, Journal of hepatology.

[42]  J. Kao,et al.  Phylogenetic analysis of GB virus C: comparison of isolates from Africa, North America, and Taiwan. , 1996, The Journal of infectious diseases.

[43]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[44]  O. Traoré,et al.  Hepatitis B, C, D, and E markers in rural equatorial African villages (Gabon). , 1995, The American journal of tropical medicine and hygiene.

[45]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[46]  D. Bradley,et al.  Non-A, Non-B Hepatitis Unrelated to the Hepatitis C Virus (Non-ABC) , 1995, Seminars in liver disease.

[47]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[48]  E. Delaporte,et al.  High level of hepatitis C endemicity in Gabon, equatorial Africa. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  E. Delaporte,et al.  Population-based study of serum hepatitis B virus DNA in Gabon. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[50]  J. Chiba,et al.  Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long‐term follow‐up , 1993, Journal of medical virology.

[51]  G. Nemo,et al.  Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. , 1992, The New England journal of medicine.

[52]  G. Nemo,et al.  HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .

[53]  R. Purcell,et al.  Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis , 1990 .

[54]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[55]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.